欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/0265/001
药品名称NuvaRing
活性成分
    • Ethinylestradiol 2.7 mg
    • Etonogestrel 11.7 mg
剂型Vaginal device
上市许可持有人N.V. Organon Kloosterstraat 6 P.O. box 20 5340 BH Oss the Netherlands
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Germany (DE)
    • Denmark (DK)
    • Belgium (BE)
    • Luxembourg (LU)
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      NuvaRing-Vaginalring
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      NuvaRing
    • Latvia (LV)
      NuvaRing 120/15 mikrogrami/24 stundās vaginālā sistēma
    • Lithuania (LT)
      NuvaRing 120/15 mikrogramų/24 valandas vartojimo į makštį sistema
    • Estonia (EE)
    • Hungary (HU)
      Nuvaring hüvelygyűrű
    • Czechia (CZ)
      NuvaRing, 0,120mg/0,015mg Vaginal delivery system
    • Romania (RO)
      NUVARING, 0,120 mg/0,015 mg per 24 de ore, sistem cu cedare vaginală
    • Slovakia (SK)
      NuvaRing 0,120mg/0,015mg vaginálny inzert
    • Slovenia (SI)
    • Malta (MT)
许可日期2001/06/12
最近更新日期2025/09/08
药物ATC编码
    • G02BB01 vaginal ring with progestogen and estrogen
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Fixed Combination Article 4.8b
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase